Insider Stock Trading History of Better Marc


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Better Marc since year 2005. The trader's CIK number is 1609642. At the time of this reporting, Better Marc is the VP, Product Sciences of Kite Pharma, Inc. . (stock ticker symbol KITE). See this page for all insider trading activities at Kite Pharma, Inc. .


Stock purchases, sales, and option exercises reported by insider Better Marc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-02-01 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2016-02-01 KITE Kite Pharma, Inc. Sale 9,000 47.89 430,992
2016-01-04 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2016-01-04 KITE Kite Pharma, Inc. Sale 9,000 61.73 555,570
2015-12-01 KITE Kite Pharma, Inc. Sale 9,000 77.95 701,514
2015-12-01 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2015-11-02 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2015-11-02 KITE Kite Pharma, Inc. Sale 9,000 70.59 635,310
2015-10-01 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2015-10-01 KITE Kite Pharma, Inc. Sale 9,000 55.38 498,384
2015-09-01 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2015-09-01 KITE Kite Pharma, Inc. Sale 9,000 52.20 469,800
2015-08-03 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2015-08-03 KITE Kite Pharma, Inc. Sale 9,000 72.64 653,760
2015-07-01 KITE Kite Pharma, Inc. Sale 9,000 61.97 557,757
2015-07-01 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2015-06-01 KITE Kite Pharma, Inc. Sale 9,000 55.48 499,292
2015-06-01 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2015-05-01 KITE Kite Pharma, Inc. Option Ex 9,000 .38 3,420
2015-05-01 KITE Kite Pharma, Inc. Sale 9,000 51.02 459,207

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Better Marc (VP, Product Sciences of Kite Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.